WEBSITE BSE:544021 NSE : PROTEAN 10 May, 16:01
Market Cap ₹4672 Cr.
Stock P/E 47.2
P/B 5
Current Price ₹1155.1
Book Value ₹ 229
Face Value 10
52W High ₹1712
Dividend Yield 0.87%
52W Low ₹ 775
Protean e-Gov Technologies Ltd is a cutting-edge technology company specializing in e-Governance solutions. Established with a vision to transform public service delivery, the company leverages innovative technologies to streamline government processes, enhance transparency, and facilitate citizen-centric services. Protean e-Gov excels in developing custom software solutions, digital platforms, and integrated systems tailored to the unique requirements of government agencies. Their expertise spans various domains, including civic administration, healthcare, education, and more. Committed to catalyzing digital transformation in the public sector, Protean e-Gov Technologies Ltd stands as a leader in fostering efficient, accessible, and technologically advanced governance solutions.
Price goes above X
Price falls below X
PE goes above X
PE falls below X
₹ | |
#(Fig in Cr.) | Sep 2022 | Dec 2022 | Mar 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|---|
Net Sales | 178 | 176 | 232 | 236 | 204 | 222 |
Other Income | 10 | 10 | 11 | 13 | 29 | 13 |
Total Income | 188 | 186 | 243 | 248 | 233 | 235 |
Total Expenditure | 148 | 143 | 197 | 199 | 207 | 200 |
Operating Profit | 39 | 43 | 46 | 49 | 26 | 35 |
Interest | 0 | 0 | 0 | 0 | 1 | 1 |
Depreciation | 5 | 5 | 5 | 5 | 6 | 11 |
Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 |
Profit Before Tax | 34 | 38 | 41 | 43 | 19 | 24 |
Provision for Tax | 9 | 9 | 9 | 11 | 4 | 4 |
Profit After Tax | 26 | 28 | 32 | 33 | 15 | 19 |
Adjustments | 0 | 0 | 0 | 0 | 0 | 0 |
Profit After Adjustments | 26 | 28 | 32 | 33 | 15 | 19 |
Adjusted Earnings Per Share | 6.4 | 7 | 7.8 | 8.1 | 3.8 | 4.8 |
#(Fig in Cr.) | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | TTM |
---|---|---|---|---|---|---|
Net Sales | 756 | 716 | 603 | 691 | 742 | 894 |
Other Income | 35 | 39 | 49 | 79 | 42 | 66 |
Total Income | 791 | 755 | 652 | 770 | 784 | 959 |
Total Expenditure | 589 | 568 | 518 | 567 | 624 | 803 |
Operating Profit | 202 | 186 | 134 | 203 | 160 | 156 |
Interest | 0 | 2 | 1 | 0 | 1 | 2 |
Depreciation | 20 | 27 | 17 | 17 | 18 | 27 |
Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 |
Profit Before Tax | 182 | 158 | 116 | 186 | 140 | 127 |
Provision for Tax | 57 | 36 | 24 | 42 | 33 | 28 |
Profit After Tax | 124 | 122 | 92 | 144 | 107 | 99 |
Adjustments | 0 | 0 | 0 | 0 | 0 | 0 |
Profit After Adjustments | 124 | 122 | 92 | 144 | 107 | 99 |
Adjusted Earnings Per Share | 31.1 | 30.5 | 23 | 35.6 | 26.5 | 24.5 |
# | 1 Year | 3 Year | 5 Year | 10 Year |
---|---|---|---|---|
Sales CAGR | 7% | 1% | 0% | 0% |
Operating Profit CAGR | -21% | -5% | 0% | 0% |
PAT CAGR | -26% | -4% | 0% | 0% |
# | 1 Year | 3 Year | 5 Year | 10 Year |
---|---|---|---|---|
Share Price CAGR | NA% | NA% | NA% | NA% |
ROE Average | 13% | 15% | 16% | 16% |
ROCE Average | 17% | 20% | 22% | 22% |
#(Fig in Cr.) | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
---|---|---|---|---|---|
Shareholder's Funds | 666 | 754 | 668 | 788 | 857 |
Minority's Interest | 0 | -0 | -0 | -0 | -0 |
Borrowings | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 7 | 15 | 14 | 5 | -1 |
Total Current Liabilities | 176 | 168 | 172 | 176 | 228 |
Total Liabilities | 849 | 937 | 853 | 968 | 1083 |
Fixed Assets | 135 | 63 | 56 | 65 | 63 |
Other Non-Current Assets | 384 | 442 | 326 | 362 | 612 |
Total Current Assets | 330 | 350 | 388 | 542 | 408 |
Total Assets | 849 | 937 | 853 | 968 | 1083 |
#(Fig in Cr.) | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
---|---|---|---|---|---|
Opening Cash & Cash Equivalents | 46 | 39 | 41 | 73 | 207 |
Cash Flow from Operating Activities | 127 | 54 | 100 | 94 | 137 |
Cash Flow from Investing Activities | -103 | -13 | 116 | 73 | -282 |
Cash Flow from Financing Activities | -31 | -39 | -183 | -34 | -44 |
Net Cash Inflow / Outflow | -7 | 2 | 32 | 133 | -190 |
Closing Cash & Cash Equivalent | 39 | 41 | 73 | 207 | 17 |
# | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
---|---|---|---|---|---|
Earnings Per Share (Rs) | 31.07 | 30.48 | 22.97 | 35.64 | 26.48 |
CEPS(Rs) | 36.04 | 37.21 | 27.15 | 39.85 | 31.01 |
DPS(Rs) | 7.8 | 10 | 44 | 10 | 10 |
Book NAV/Share(Rs) | 165.64 | 187.18 | 165.19 | 194.62 | 211.28 |
Core EBITDA Margin(%) | 22.07 | 20.63 | 14.07 | 17.92 | 15.89 |
EBIT Margin(%) | 24.04 | 22.24 | 19.39 | 26.94 | 19.04 |
Pre Tax Margin(%) | 24.02 | 22.01 | 19.23 | 26.87 | 18.92 |
PAT Margin (%) | 16.44 | 17.02 | 15.28 | 20.83 | 14.42 |
Cash Profit Margin (%) | 19.07 | 20.79 | 18.07 | 23.29 | 16.89 |
ROA(%) | 14.64 | 13.65 | 10.3 | 15.8 | 10.44 |
ROE(%) | 18.76 | 17.26 | 13.06 | 19.87 | 13.05 |
ROCE(%) | 27.29 | 22.43 | 16.46 | 25.57 | 17.18 |
Receivable days | 87.78 | 100.05 | 123.59 | 105.17 | 100.63 |
Inventory Days | 0 | 0 | 0 | 0 | 0 |
Payable days | 0 | 0 | 0 | 0 | 0 |
PER(x) | 0 | 0 | 0 | 0 | 0 |
Price/Book(x) | 0 | 0 | 0 | 0 | 0 |
Dividend Yield(%) | 0 | 0 | 0 | 0 | 0 |
EV/Net Sales(x) | -0.02 | -0.01 | -0.12 | -0.28 | -0.13 |
EV/Core EBITDA(x) | -0.08 | -0.05 | -0.56 | -0.95 | -0.61 |
Net Sales Growth(%) | 0 | -5.3 | -15.78 | 14.55 | 7.42 |
EBIT Growth(%) | 0 | -12.42 | -26.56 | 59.14 | -24.05 |
PAT Growth(%) | 0 | -1.97 | -24.35 | 56.14 | -25.63 |
EPS Growth(%) | 0 | -1.91 | -24.64 | 55.2 | -25.7 |
Debt/Equity(x) | 0 | 0 | 0 | 0 | 0 |
Current Ratio(x) | 1.87 | 2.08 | 2.26 | 3.08 | 1.79 |
Quick Ratio(x) | 1.87 | 2.08 | 2.26 | 3.08 | 1.79 |
Interest Cover(x) | 1010.11 | 98.11 | 123.75 | 385.31 | 152.48 |
Total Debt/Mcap(x) | 0 | 0 | 0 | 0 | 0 |
# | Sep 2015 | Sep 2016 | Sep 2017 | Aug 2018 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|---|
Promoter | 61.88 | 61.88 | 36.83 | 0 | 0 | 0 |
FII | 0 | 0 | 0 | 0 | 1.27 | 0.37 |
DII | 35 | 35 | 35 | 0 | 60.4 | 50.34 |
Public | 3.13 | 3.13 | 28.17 | 100 | 38.32 | 49.29 |
Others | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 100 | 100 | 100 | 100 | 100 | 100 |
# | Sep 2015 | Sep 2016 | Sep 2017 | Aug 2018 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|---|
Promoter | 2.48 | 2.48 | 1.47 | 0 | 0 | 0 |
FII | 0 | 0 | 0 | 0 | 0.05 | 0.02 |
DII | 1.4 | 1.4 | 1.4 | 0 | 2.44 | 2.04 |
Public | 0.13 | 0.13 | 1.13 | 4 | 1.55 | 1.99 |
Others | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 4 | 4 | 4 | 4 | 4.04 | 4.04 |
Pros
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
You May Also Know About